Samay

📍 Mountain View, United States🗓 Founded 2019👥 278 employees💰 Last funded May 2026
Hospitals and Health Care🌐 samayhealth.com
Website LinkedIn
Samay has cracked the code on respiratory diagnostics with Sylvee—our AI-enabled chest sensor that outperforms existing tools by 2x. Protected by 12 patents and backed by $5M+ from NSF, NIH, VCs, and pharma partners, Sylvee achieves breakthrough accuracy: 90%+ precision in COPD detection and 80% accuracy in air trapping identification. Our integrated platform delivers what the market desperately needs: early COPD diagnosis, continuous remote monitoring, and biomarker discovery for 550+ million patients worldwide—80% of whom remain undiagnosed. The impact? Preventing millions of premature deaths while reducing the $143B annual COPD expenses through partnerships with healthcare systems and pharmaceutical companies.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2019
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Australia
1
Frequently asked questions
Who invested in Samay?
Samay has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Samay last raise funding?
The most recent investment in Samay recorded on gritt.io was in May 2026.
When was Samay founded?
Samay was founded in 2019.
What industry is Samay in?
Samay operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is Samay based?
Samay is headquartered in Mountain View, United States.